Comparison of the Clinical Results of Platelet-Rich Plasma, Steroid and Autologous Blood Injections in the Treatment of Chronic Lateral Epicondylitis

Aybars Kıvrak, Ibrahim Ulusoy, Aybars Kıvrak, Ibrahim Ulusoy

Abstract

Background: The aim of our study is to compare the efficacy of PRP, steroids, and autologous blood injection in patients with chronic lateral epicondylitis.

Method: A total of 120 patients comprised our study. Three groups of 40 patients each received only one of the following: PRP, steroids, or autologous blood injections. Thereafter, VAS (visual analog scale), DASH (Disabilities of the Arm, Shoulder, and Hand), and Nirschl scores of those treated were evaluated in the second week, the fourth week, the third month, and the sixth month.

Results: The baseline evaluation revealed no significant change in VAS, DASH, and Nirschl scores among the three groups (p > 0.050). At the second week evaluation, patients treated with steroids showed significant improvement compared to patients treated with PRP and autologous blood (p < 0.001). The fourth-week evaluation revealed the VAS, DASH, and Nirschl scores of the patients treated with steroids to have improved more significantly than those of patients treated with PRP and autologous blood (p < 0.001). The third month, when the results of all three groups were compared, revealed similar results (p > 0.050). The sixth-month evaluation, when the results of all three groups were compared, revealed the autologous blood and PRP applications provided significantly better results than the group treated with steroids (p < 0.001).

Conclusion: We concluded that steroid administration is effective in the short term, while PRP and autologous blood applications are more effective than steroid administration in the long term.

Keywords: PRP; VAS; autologous whole blood injection; chronic; elbow; injection; lateral epicondylitis; steroid.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Distribution of patient groups by age.
Figure 2
Figure 2
Mean unit improvement in DASH score.
Figure 3
Figure 3
Mean unit improvement in Nirschl score.
Figure 4
Figure 4
Mean unit improvement in visual analog scale pain score.

References

    1. Ben-Nafa W., Munro W. The effect of corticosteroid versus platelet-rich plasma injection therapies for the management of lateral epicondylitis: A systematic review. SICOT-J. 2018;4:11. doi: 10.1051/sicotj/2017062.
    1. Hong Q.N., Durand M.J., Loisel P. Treatment of lateral epicondylitis: Where is the evidence? Jt. Bone Spine. 2004;71:369–373. doi: 10.1016/j.jbspin.2003.05.002.
    1. Ahmad Z., Siddiqui N., Malik S.S., Abdus-Samee M., Tytherleigh-Strong G., Rushton N. Lateral epicondylitis: A review of pathology and management. Bone Jt. J. 2013;95:1158–1164. doi: 10.1302/0301-620X.95B9.29285.
    1. Arirachakaran A., Sukthuayat A., Sisayanarane T., Laoratanavoraphong S., Kanchanatawan W., Kongtharvonskul J. Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: Systematic review and network meta-analysis. J. Orthop. Traumatol. 2015;17:101–112. doi: 10.1007/s10195-015-0376-5.
    1. Krogh T.P., Fredberg U., Stengaard-Pedersen K., Christensen R., Jensen P., Ellingsen T. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: A randomized, double-blind, placebo-controlled trial. Am. J. Sport. Med. 2013;41:625–635. doi: 10.1177/0363546512472975.
    1. Linnanmäki L., Kanto K., Karjalainen T., Leppänen O.V., Lehtinen J. Platelet-rich plasma or autologous blood do not reduce pain or improve function in patients with lateral epicondylitis: A Randomized Controlled Trial. Clin. Orthop. Relat. Res. 2020;478:1892–1900. doi: 10.1097/CORR.0000000000001185.
    1. Tang S., Wang X., Wu P., Wu P., Yang J., Du Z., Liu S., Wei F. Platelet-Rich Plasma Vs Autologous Blood Vs Corticosteroid Injections in the Treatment of Lateral Epicondylitis: A Systematic Review, Pairwise and Network Meta-Analysis of Randomized Controlled Trials. PMR. 2020;12:397–409. doi: 10.1002/pmrj.12287.
    1. Anitua E. Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int. J. Oral Maxillofac. Implant. 1999;14:529–535.
    1. Anitua E., Andia I., Ardanza B., Nurden P., Nurden A. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb. Haemost. 2004;91:4–15. doi: 10.1160/TH03-07-0440.
    1. Graziani F., Ivanovski S., Cei S., Ducci F., Tonetti M., Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin. Oral Implant. Res. 2005;17:212–219. doi: 10.1111/j.1600-0501.2005.01203.x.
    1. Hay E.M., Paterson S.M., Lewis M., Hosie G., Croft P. Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care. BMJ. 1999;319:964–968. doi: 10.1136/bmj.319.7215.964.
    1. Smidt N., van der Windt D.A., Assendelft W.J., Devillé W.L., Bos I.B.K.-D., Bouter L.M. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: A randomised controlled trial. Lancet. 2002;359:657–662. doi: 10.1016/S0140-6736(02)07811-X.
    1. Yi R., Bratchenko W.W., Tan V. Deep Friction Massage Versus Steroid Injection in the Treatment of Lateral Epicondylitis. Hand. 2017;13:56–59. doi: 10.1177/1558944717692088.
    1. Reddy V.V., Chandru V., Patel I., Sv G. Comparison between Corticosteroid, Platelet Rich Plasma (PRP) and Xylocaine Infiltration for Lateral Epicondylosis (Tennis Elbow): A Prospective Randomized Study. J. Trauma Treat. 2016;5:1000304.
    1. Rodik T., McDermott B. Platelet-rich plasma compared with other common injection therapies in the treatment of chronic lateral epicondylitis. J. Sport Rehabil. 2016;25:77–82. doi: 10.1123/jsr.2014-0198.
    1. Shakeel H., Ahmad T.S. Steroid injection versus NSAID injection for trigger finger: A comparative study of early outcomes. J. Hand Surg. 2012;37:1319–1323. doi: 10.1016/j.jhsa.2012.03.040.
    1. Oxlund H. Long term local cortisol treatment of tendons and the indirect effect on skin. Scand. J. Plast. Reconstr. Surg. 1982;16:61–66. doi: 10.3109/02844318209006571.
    1. Arik H.O., Kose O., Guler F., Deniz G., Egerci O.F., Ucar M. Injection of autologous blood versus corticosteroid for lateral epicondylitis: A randomised controlled study. J. Orthop. Surg. 2014;22:333–337. doi: 10.1177/230949901402200313.
    1. Ozturan K.E., Yucel I., Cakici H., Guven M., Sungur I. Autologous blood and corticosteroid injection and extracoporeal shock wave therapy in the treatment of lateral epicondylitis. Orthopedics. 2010;33:84–91. doi: 10.3928/01477447-20100104-9.
    1. GEDİK D.E., SÜRÜCÜ G.D., KARABİBER M., YILDIRIM A. LATERAL EPİKONDİLİT TEDAVİSİNDE OTOLOG KAN ENJEKSİYONUNUN ETKİNLİĞİ: RANDOMİZE KLİNİK ÇALIŞMA. Duzce Med. J. 2016;18:1–7.
    1. Brkljac M., Conville J., Sonar U., Kumar S. Long-term follow-up of platelet-rich plasma injections for refractory lateral epicondylitis. J. Orthop. 2019;16:496–499. doi: 10.1016/j.jor.2019.08.023.
    1. Mishra A.K., Skrepnik N.V., Edwards S.G., Jones G.L., Sampson S., Vermillion D.A., Ramsey M.L., Karli D.C., Rettig A.C. Efficacy of platelet-rich plasma for chronic tennis elbow: A double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am. J. Sport. Med. 2014;42:463–471. doi: 10.1177/0363546513494359.
    1. Crane D., Everts P. Platelet rich plasma (PRP) matrix grafts. Pract. Pain Manag. 2008;8:11–26.
    1. Sampson S., Gerhardt M., Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: A review. Curr. Rev. Musculoskelet. Med. 2008;1:165–174. doi: 10.1007/s12178-008-9032-5.
    1. Tate K.S., Crane D. Platelet rich plasma grafts in musculoskeletal medicine. J. Prolotherapy. 2010;2:371–376.
    1. Mishra A., Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am. J. Sport. Med. 2006;34:1774–1778. doi: 10.1177/0363546506288850.
    1. Thanasas C., Papadimitriou G., Charalambidis C., Paraskevopoulos I., Papanikolaou A. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: A randomized controlled clinical trial. Am. J. Sport. Med. 2011;39:2130–2134. doi: 10.1177/0363546511417113.
    1. Dhillon R.S., Schwarz E.M., Maloney M.D. Platelet-rich plasma therapy-future or trend? Arthritis Res. Ther. 2012;14:219. doi: 10.1186/ar3914.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere